CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Agreement ended · Executive or director change · Code of ethics change · Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 7,500 shares at $8.11 ($60,825)
- 4 Open-market buy 10% owner bought 25,000 shares at $8.03 ($200,735)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 9,778 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Bylaws or fiscal year change
- 4 Open-market buy 10% owner bought 20,000 shares at an average $14.60 ($292,076)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Chief Executive Officer bought 5,800 shares at $17.05 ($98,890)
- 4 Open-market buy Director bought 20,000 shares at $16.92 ($338,400)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 8 of 44 · 872 filings